MedPath

Elucidation of the effect of Omega-3-Acid ethyl esters for CKD patients with dyslipidemia, compared to ethyl icosapentate

Not Applicable
Conditions
CKD patients with dyslipidemia
Registration Number
JPRN-UMIN000013149
Lead Sponsor
Department of Internal Medicine, Division of Nephrology, Juntendo University Faculty of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who are bleeding 2) Past medical history of hypersensitivity to Lotriga 3) Judged as ineligible by physicians

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath